{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Multivalent+Pneumococcal+Vaccine+-+Formulation+2",
    "query": {
      "intervention": "Multivalent Pneumococcal Vaccine - Formulation 2"
    },
    "page_size": 10
  },
  "pagination": {
    "page": 1,
    "page_size": 10,
    "total_count": 3,
    "total_pages": 1,
    "next_page_url": null,
    "previous_page_url": null
  },
  "source": "remote",
  "last_synced_at": "2026-09-02T14:17:36.499Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT06182124",
      "title": "A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Pneumococcal Disease"
      ],
      "interventions": [
        {
          "name": "Multivalent Pneumococcal Vaccine - Formulation 1",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Multivalent Pneumococcal Vaccine - Formulation 2",
          "type": "BIOLOGICAL"
        },
        {
          "name": "20-valent pneumococcal conjugate vaccine (20vPnC)",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Licensed pneumococcal comparator vaccine",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Multivalent Pneumococcal Vaccine - Formulation 3",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Multivalent Pneumococcal Vaccine - Formulation 4",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Pfizer",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 1363,
      "start_date": "2023-12-20",
      "completion_date": "2026-05-12",
      "has_results": false,
      "last_update_posted_date": "2026-06-10",
      "last_synced_at": "2026-09-02T14:17:36.499Z",
      "location_count": 20,
      "location_summary": "Doral, Florida • Hialeah, Florida • Stockbridge, Georgia + 13 more",
      "locations": [
        {
          "city": "Doral",
          "state": "Florida"
        },
        {
          "city": "Hialeah",
          "state": "Florida"
        },
        {
          "city": "Stockbridge",
          "state": "Georgia"
        },
        {
          "city": "Peoria",
          "state": "Illinois"
        },
        {
          "city": "New Orleans",
          "state": "Louisiana"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06182124"
    },
    {
      "nct_id": "NCT03642847",
      "title": "Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Pneumococcal Infections"
      ],
      "interventions": [
        {
          "name": "Prevnar 13",
          "type": "BIOLOGICAL"
        },
        {
          "name": "multivalent pneumococcal conjugate formulation 1",
          "type": "BIOLOGICAL"
        },
        {
          "name": "multivalent pneumococcal conjugate formulation 2",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Pfizer",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "49 Years",
        "sex": "ALL",
        "summary": "18 Years to 49 Years"
      },
      "enrollment_count": 104,
      "start_date": "2018-08-29",
      "completion_date": "2019-03-29",
      "has_results": false,
      "last_update_posted_date": "2019-06-12",
      "last_synced_at": "2026-09-02T14:17:36.499Z",
      "location_count": 4,
      "location_summary": "Garden Grove, California • Long Beach, California • Honolulu, Hawaii + 1 more",
      "locations": [
        {
          "city": "Garden Grove",
          "state": "California"
        },
        {
          "city": "Long Beach",
          "state": "California"
        },
        {
          "city": "Honolulu",
          "state": "Hawaii"
        },
        {
          "city": "Eatontown",
          "state": "New Jersey"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03642847"
    },
    {
      "nct_id": "NCT05831124",
      "title": "A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Pneumococcal Disease"
      ],
      "interventions": [
        {
          "name": "Low dose multivalent pneumococcal conjugate vaccine formulation A",
          "type": "OTHER"
        },
        {
          "name": "Low dose multivalent pneumococcal conjugate vaccine formulation B",
          "type": "OTHER"
        },
        {
          "name": "Low dose of multivalent pneumococcal conjugate vaccine control",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Standard dose multivalent pneumococcal conjugate vaccine control",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "OTHER",
        "BIOLOGICAL"
      ],
      "sponsor": "Pfizer",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "50 Years",
        "maximum_age": "64 Years",
        "sex": "ALL",
        "summary": "50 Years to 64 Years"
      },
      "enrollment_count": 90,
      "start_date": "2023-04-19",
      "completion_date": "2024-06-26",
      "has_results": false,
      "last_update_posted_date": "2024-07-29",
      "last_synced_at": "2026-09-02T14:17:36.499Z",
      "location_count": 9,
      "location_summary": "Hialeah, Florida • Hollywood, Florida • Columbia, Maryland + 4 more",
      "locations": [
        {
          "city": "Hialeah",
          "state": "Florida"
        },
        {
          "city": "Hollywood",
          "state": "Florida"
        },
        {
          "city": "Hollywood",
          "state": "Florida"
        },
        {
          "city": "Columbia",
          "state": "Maryland"
        },
        {
          "city": "Elkridge",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05831124"
    }
  ]
}